De-escalation therapy among bacteraemic patients with community-acquired pneumonia

Clinical Microbiology and Infection

Volumn 21, Issue 10, 2015, Pages 936.e11-936.e18

  Carugati, M ^a   Franzetti, F ^a   Wiemken, T ^b   Kelly, R ^b   Peyrani, P ^b   Blasi, F ^a   Ramirez, J ^b   Aliberti, S ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Bacteraemia; Broad spectrum antibiotic treatment; Community acquired pneumonia; De escalation; Sepsis

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CLINDAMYCIN; LINEZOLID; MACROLIDE; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DE ESCALATION THERAPY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; MIDDLE AGED; PNEUMONIA, BACTERIAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84942198767     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.06.015     Document Type: Article

References (32)

1. Levy M.M., Artigas A., Phillips G.S., Rhodes A., Beale R., Osborn T., et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012, 12:919-924.
2. Blasi F., Garau J., Medina J., Avila M., McBride K., Ostermann H., et al. Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respir Res 2013, 14:44.
3. American Thoracic Society Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
4. Leone M., Martin C. How to break the vicious circle of antibiotic resistances?. Curr Opin Crit Care 2008, 14:587-592.
5. Rello J., Vidaur L., Sandiumenge A., Rodriguez A., Gualis B., Boque C., et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004, 32:2183-2190.
6. Leone M., Bechis C., Baumstarck K., Lefrant J.Y., Albanese J., Jaber S., et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 2014, 40:1399-1408.
7. Garnacho-Montero J., Gutierrez-Pizarraya A., Escoresca-Ortega A., Corcia-Palomo Y., Fernandez-Delgado E., Herrera-Melero I., et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 2014, 40:32-40.
8. Mokart D., Slehofer G., Lambert J., Sannini A., Chow-Chine L., Brun J.P., et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 2014, 40:41-49.
9. Shime N., Kosaka T., Fujita N. De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat Gram-negative bacilli. Infection 2013, 41:203-210.
10. Morel J., Casoetto J., Jospe R., Aubert G., Terrana R., Dumont A., et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care 2010, 14:R225.
11. Cremers A.J., Sprong T., Schouten J.A., Walraven G., Hermans P.W., Meis J.F., et al. Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia. J Antimicrob Chemother 2014, 69:2258-2264.
12. Shime N., Satake S., Fujita N. De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients. Infection 2011, 39:319-325.
13. Silva B.N., Andriolo R.B., Atallah A.N., Salomao R. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 2013, 3:CD007934.
14. Arnold F.W., Summersgill J.T., Lajoie A.S., Peyrani P., Marrie T.J., Rossi P., et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007, 175:1086-1093.
15. Weinstein M.P. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis 1996, 23:40-46.
16. Aliberti S., Peyrani P., Filardo G., Mirsaeidi M., Amir A., Blasi F., et al. Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. Chest 2011, 140:482-488.
17. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
18. Kollef M.H. Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Crit Care Med 2001, 29:1473-1475.
19. Leone M., Garcin F., Bouvenot J., Boyadjev I., Visintini P., Albanese J., et al. Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse. Crit Care Med 2007, 35:379-385. quiz 86.
20. Niederman M.S. De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care 2006, 12:452-457.
21. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl. 2):S27-S72.
22. Woodhead M., Blasi F., Ewig S., Garau J., Huchon G., Ieven M., et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect 2011, 17(Suppl. 6):E1-E59.
23. Aliberti S., Di Pasquale M., Zanaboni A.M., Cosentini R., Brambilla A.M., Seghezzi S., et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012, 54:470-478.
24. Wisplinghoff H., Edmond M.B., Pfaller M.A., Jones R.N., Wenzel R.P., Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000, 31:690-697.
25. Aliberti S., Zanaboni A.M., Wiemken T., Nahas A., Uppatla S., Morlacchi L.C., et al. Criteria for clinical stability in hospitalised patients with community-acquired pneumonia. Eur Respir J 2013, 42:742-749.
26. Aliberti S., Amir A., Peyrani P., Mirsaeidi M., Allen M., Moffett B.K., et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest 2008, 134:955-962.
27. Zou G.A. modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004, 159:702-706.
28. Zeileis A. Object-oriented computation of sandwich estimators. J Stat Softw 2006, 16:1-16.
29. Harrell F.E. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis 2001, Springer, New York.
30. Koupetori M., Retsas T., Antonakos N., Vlachogiannis G., Perdios I., Nathanail C., et al. Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome. BMC Infect Dis 2014, 14:272.
31. Joung M.K., Lee J.A., Moon S.Y., Cheong H.S., Joo E.J., Ha Y.E., et al. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care 2011, 15:R79.
32. Heenen S., Jacobs F., Vincent J.L. Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?. Crit Care Med 2012, 40:1404-1409.